Ritonavir: an extraordinary example of conformational polymorphism
about
sameAs
Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallizationModelling temperature-dependent properties of polymorphic organic molecular crystals.Crystal Nucleation in Liquids: Open Questions and Future Challenges in Molecular Dynamics Simulations.Parallel thermal analysis technology using an infrared camera for high-throughput evaluation of active pharmaceutical ingredients: a case study of melting point determination.Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.Parts per Million Powder X-ray Diffraction.Characterization of a sulfadiazine-induced lithiasis calculus by physicochemical techniques.Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.Kinetic trapping of metastable amino acid polymorphs.Disappearing polymorphs revisited.Solvation and surface effects on polymorph stabilities at the nanoscaleCan computed crystal energy landscapes help understand pharmaceutical solids?Blending gelators to tune gel structure and probe anion-induced disassembly.Polymorphs of Theophylline Characterized by DNP Enhanced Solid-State NMR.Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.Combined crystal structure prediction and high-pressure crystallization in rational pharmaceutical polymorph screening.Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto Neusilin® US2.Pharmaceutical polymorph control in a drug-mimetic supramolecular gel.Epitaxial Retrieval of a Disappearing Polymorph.Influences of Crystal Anisotropy in Pharmaceutical Process Development.Survey and analysis of crystal polymorphism in organic structures.Machine learning for the structure-energy-property landscapes of molecular crystals.Predicting finite-temperature properties of crystalline carbon dioxide from first principles with quantitative accuracy.
P2860
Q24553346-5522F66C-F405-4307-AFDD-E2146CED3D84Q30357005-E142EDD2-6F85-463F-B18C-E0E5D5570ED0Q31102557-FCEEADB5-2D61-4A3F-A657-B323E735961FQ34280366-C4B48582-E513-41CE-B757-4833163814D4Q34757166-7EDDA7E8-B16A-4633-9AF3-6DA5990E8F84Q34990288-924178B0-5CE2-4839-9C8A-46BFF11B3451Q36561968-1490C073-4B4F-4B37-8C91-90EAA27F9CEBQ36636554-95A954A1-959F-4793-BD69-DC94982FCBBDQ37065997-1FD4FC73-FD11-4232-8CD9-AE8587FBAD92Q37679129-001FFE34-810A-48F9-BC18-AE3B28718848Q38510810-F7184FFD-BF3B-401E-88DA-963174B4BF7CQ38752327-CD71F8B9-8190-4A35-8DBA-CA6B0BF1ED62Q38805031-87F11BE8-259D-4607-9FF1-9EF5FF622A00Q38881905-C1F5BA41-3D73-4D86-803B-DBA39E72E4AAQ41290111-9E93DD43-4D7B-4FCB-8C36-F3CD280C8160Q41890029-6B2A1A1B-AF7E-431D-9CBA-6CBC2BB40677Q42044900-87485ED9-89CA-467D-A637-38605E5B5C76Q42216132-BD91EBDE-5143-4AF8-9372-C6B7E04BF259Q42322036-D0F5A186-90F8-453F-85DF-44C7B006A3F8Q43102833-D28D737A-64AE-4DC2-9DEB-61279CEDECACQ53430569-F36AB450-9145-4A30-9D29-E77592FC8179Q54943838-DC340230-58CC-4037-8BCD-5612FCB8955DQ55280873-64890FFB-11D3-4E60-B414-881ECBB00C4DQ55426866-99ED1EA3-979E-4AB1-81D4-7CFF21E87356
P2860
Ritonavir: an extraordinary example of conformational polymorphism
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ritonavir: an extraordinary example of conformational polymorphism
@ast
Ritonavir: an extraordinary example of conformational polymorphism
@en
Ritonavir: an extraordinary example of conformational polymorphism
@nl
type
label
Ritonavir: an extraordinary example of conformational polymorphism
@ast
Ritonavir: an extraordinary example of conformational polymorphism
@en
Ritonavir: an extraordinary example of conformational polymorphism
@nl
prefLabel
Ritonavir: an extraordinary example of conformational polymorphism
@ast
Ritonavir: an extraordinary example of conformational polymorphism
@en
Ritonavir: an extraordinary example of conformational polymorphism
@nl
P2093
P1476
Ritonavir: an extraordinary example of conformational polymorphism
@en
P2093
P304
P407
P577
2001-06-01T00:00:00Z